Municipal Public Health Services once again conduct more STI consultations than before COVID-19 The number of STI consultations at the Sexual Health Centres of the Municipal Public Health Services (GGDs) was 19% higher in 2022 compared to 2021.
Number of tuberculosis patients in the Netherlands decreased slightly in 2022 compared to 2021 The number of people with tuberculosis (TB) in the Netherlands decreased slightly in 2022. In 2022, there were 635 TB patients in the Netherlands. This is six per cent fewer than in 2021, when there were 673 patients.
Details of proposed European PFAS ban released Today, the European Chemicals Agency (ECHA) published details of a proposed ban on the production, use, sale and import of some 10,000 per- and polyfluoroalkyl substances (PFAS).
Proposed European PFAS ban officially submitted The Netherlands, Germany, Denmark, Sweden and Norway today took the first formal step towards a European ban on per- and polyfluoroalkyl substances (PFAS) by jointly submitting a restriction proposal to the European Chemicals Agency (ECHA).
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
Annual report ‘Tuberculosis in the Netherlands’ for 2021: slight increase in number of TB patients In 2021, the number of tuberculosis (TB) patients in the Netherlands rose slightly compared to the preceding year: up to 680 TB patients from 622 in 2020. However, the 2021 number was lower than the number for 2019 (754 patients).
PFAS levels in drinking water from river water need to be brought down The National Institute for Public Health and the Environment (RIVM) advises to reduce PFAS concentrations in the drinking water in parts of the Netherlands in the coming years. This concerns drinking water produced from river water.
Nationwide study into chlamydia and gonorrhoea Today, the National Institute for Public Health and the Environment (RIVM) launches a nationwide study into chlamydia and gonorrhoea.
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
Number of STI tests at sexual health centres are rising again In 2021, more than 138,000 people were tested for sexually transmitted infections (STIs) at a centre for sexual health.